Quantcast
Home > Quotes > STAA
STAA

STAAR Surgical Company Common Stock (STAA) Quote & Summary Data

$40.4148
*  
0.9252
2.24%
Get STAA Alerts
*Delayed - data as of Nov. 16, 2018  -  Find a broker to begin trading STAA now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
Today's High / Low
$ 42.11 / $ 40.29
Share Volume
456,735
50 Day Avg. Daily Volume
617,409
Previous Close
$ 41.34
52 Week High / Low
$ 54 / $ 13.60
Market Cap
1,783,566,110
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %

Intraday Chart

Shares Traded

Share Volume:
456,735
50 Day Avg. Daily Volume:
617,409

P/E Ratio

P/E Ratio:
505.19
Forward P/E (1y):
459.33
Earnings Per Share (EPS):
$ 0.08

Trading Range

The current last sale of $40.4148 is 197.17% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 42.11 $ 54
 Low: $ 40.29 $ 13.60

ETFs with STAA as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
0.51% iShares Microcap ETF (IWC) -14.14 (-13.13%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. We are the leading manufacturer of lenses used worldwide in corrective or "refractive" surgery. Our goal is to position our refractive lenses throughout the world as primary and premium solutions for patients seeking visual freedom from wearing glasses or contact lenses while achieving excellent visual acuity through refractive vision correction. We also make lenses for use in surgery that treats cataracts. Originally incorporated in California in 1982, STAAR Surgical Company reincorporated in Delaware in 1986. Unless the context indicates otherwise, "we," "us," the "Company," and "STAAR" refer to STAAR Surgical Company and its consolidated subsidiaries. A glossary explaining many of the technical terms used in this report begins on page 12.  ... More ...  


Risk Grade

Where does STAA fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 40.87
Open Date:
Nov. 16, 2018
Close Price:
$ 41.34
Close Date:
Nov. 16, 2018

Consensus Recommendation

Analyst Info



Another Bailout?? Why is the SEC boosting big banks and HFT's bottom lines?
x